Sponsor Announcements

ACS CINF

The American Chemical Society Division of Chemical Information is very fortunate to receive generous financial support from our sponsors to maintain the high quality of the Division’s programming and to promote communication between members at social functions at the ACS Spring 2017 National Meeting in San Francisco, CA, and to support other divisional activities during the year, including scholarships to graduate students in Chemical Information.

The Division gratefully acknowledges contribution from the following sponsors:

Gold 
ACS Publications

Silver
Journal of Chemical Information & Modeling
Royal Society of Chemistry

Bronze
Journal of Cheminformatics (Springer Nature)
Collaborative Drug Discovery
PerkinElmer
Thieme Chemistry

Contributor
Bio-Rad Laboratories
Schrödinger

Opportunities are available to sponsor Division of Chemical Information events, speakers, and material. Our sponsors are acknowledged on the CINF web site, in the Chemical Information Bulletin, on printed meeting materials, and at any events for which we use your contribution. For more information please review the Sponsorship Brochure at http://www.acscinf.org/PDF/CINF_Sponsorship_Brochure.pdf.

Please feel free to contact me if you would like more information about supporting the ACS Division of Chemical Information

Graham Douglas
Chair Pro Tem, Fundraising Committee 2017
Email: Sponsorship@acscinf.org
Tel: 510-407-0769

The ACS CINF Division is a non-profit tax-exempt organization with taxpayer ID no. 52-6054220.


ACS Reagent Chemicals

ACS Reagent Chemicals

What is ACS Reagent Chemicals?

The ACS Committee on Analytical Reagents sets purity specifications for almost 500 reagent chemicals and over 500 standard-grade reference materials. These specifications have become the de facto standards for chemicals used in many high-purity applications, with agencies like the US EPA and ASTM referencing these specifications and methods. In addition to detailing these specifications, ACS Reagent Chemicals provides general physical properties and analytical uses for all reagent chemicals, as well as guidelines for standard analytical methods.

The eleventh edition of ACS Reagent Chemicals, originally released in print, became the version of record in June 2016. In January 2017, the online edition based on the eleventh edition became available, and this version reflects the content of the eleventh edition. The first round of supplements and updates were also published online and will soon be incorporated into the content of the online edition. All content is under regular review by the Committee, and additions and updates to existing content will be integrated in the online version beginning in 2017. New mechanisms are being added for capturing the historic record moving forward.

Who benefits from access?

Academic and research institutions gain access to standards that are utilized by top organizations (the U.S. EPA and U.S. Pharmacopeia, for example) for analytical procedures. Students also benefit from access to easy-to-follow methods and highlighted handling instructions for chemicals. They also can easily find physical constants, equations, and other data in the monographs for each chemical.

Industry professionals use ACS Reagent Chemicals to check that reference materials are of an acceptable purity for the test being performed and ensure that starting materials are of high enough purity for product synthesis. Manufacturers use ACS Reagent Chemicals to ensure that their inventory of analytical and Reagent Grade chemicals meet the committee’s standards for purity.

What’s new for 2017?

The content of the new online edition is delivered on the same platform as ACS journals, providing a consistent experience for users. Additional benefits include:

  • Better user interface, paired with expanded accessibility, including mobile friendliness, helps readers find the information they need easily from wherever they are.
  • DOIs for each monograph and method.
  • All content is under regular review by the committee, with regular online additions and updates starting in 2017.
  • Each monograph will show a summary of historic changes moving forward, giving the reader full awareness of changes and a link to prior versions.
  • Internal references are hot-linked, helping readers to locate all the information they need quickly.
  • HTML and printable PDF formats help readers use the content in the format that is most convenient for them.
  • Usage, denials, and abstract data at the chapter level help librarians track utilization.

ACS Publications Numbers 2016


Collaborative Drug Discovery

CDD

USPTO Issues Collaborative Drug Discovery, Inc. (CDD) Patent

CDD has been awarded a U.S. utility patent for a “Hybrid machine-user learning system and process for identifying, accurately selecting and storing scientific data” (U.S. Patent No. 9,594,743, issued March 14, 2017).

From the desk of Mark A. Harper, Ph.D., Partner, Dinsmore & Shohl LLP, Legal Counsel (CDD’s Patent Lawyer)

The United States Patent and Trademark Office (USPTO) officially issued U.S. Patent No. 9,594,743 assigned to CDD on March 14, 2017.  The CDD patent is directed to a hybrid machine-user learning system and process for identifying, accurately selecting, and storing scientific data. This includes use in screening runs measuring drug candidates or medical knowledge bases that go into more detail about the biological systems being assayed.  After examination of the application by the USPTO, which included a review of the application, a search of prior art and a comparison of the claims of the application with the prior art uncovered during the search, the USPTO noted that the prior art “does not disclose, teach or suggest” the invention as recited in the claims.  Particularly, the USPTO noted that the scoring and ranking of possible annotations assigned to Part of Speech (POS)-tagged blocks as taught in the application and recited in the claims was novel and not obvious in view of the prior art.

The full patent abstract, images, description, and claims can be cleanly viewed in Google Patents here:
https://www.google.com/patents/US9594743

For more information on the new BAE product using this patented technology to annotate your assays more efficiently in machine-readable, semantically marked-up formats, please see the BioAssay Express (BAE) (http://www.bioassayexpress.com/) website or schedule a free demonstration via email to sales@collaborativedrug.com.

(Reproduced from https://www.collaborativedrug.com/buzz/2017/04/11/uspto-issues-cdd-patent/)


Journal of Chemical Information and Modeling

JCIM

The Journal of Chemical Information and Modeling is excited to be sponsoring the Division of Chemical Information, and our team looks forward to working with many of its members in the coming months. In the past, I mentioned changes at the journal which involved creating two new manuscript types: reviews and application notes. We have published several application notes describing software appropriate to chemical information and other areas, and we are currently in the process of publishing several reviews. If you have an idea for a review please contact me at eic@jcim.acs.org, and we can discuss your idea further. We also are expanding our support in the area of molecular simulation and materials informatics, so please consider sending your manuscripts in these areas to the journal. All the best in 2017!

Kennie Merz
Editor-in-Chief, Journal of Chemical Information and Modeling


Perkin Elmer

Perkin Elmer

April 3, 2017

New Cloud-Based PerkinElmer Signals Notebook Helps Scientists Accelerate Drug Discovery Research

ELN Leverages Cloud- and Web-based Technology to Streamline and Centralize Scientific Data

WALTHAM, Mass. – April 3, 2017PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition (Booth #619). PerkinElmer’s new cloud-based electronic laboratory notebook solution (ELN) powers smarter science through collaboration.

Researchers and lab managers can utilize the platform to quickly compile, report, and share data to accelerate drug discovery by leveraging the PerkinElmer Signals Notebook cloud to access, manage, and author notebooks or experiments in real-time. The PerkinElmer Signals Notebook also enables R&D to help accelerate the pace of innovation.

“Scientists and lab managers must have the most effective and modern data management tools at their fingertips to meet the evolving demands of drug discovery today,” said David Wang, Vice President and General Manager, Informatics, PerkinElmer. “The PerkinElmer Signals Notebook provides powerful tools to enable users to focus on achieving breakthroughs at an accelerated pace with collaborators. Further, the new cloud-based solution can be implemented immediately for a quick return on investment.”

The PerkinElmer Signals Notebook allows for simple navigation that helps researchers seamlessly store, organize, share, and find data. The platform is fully-integrated with Microsoft Office and Microsoft Office Online applications to further streamline processes such as directly attaching documents to experiments. The PerkinElmer Signals Notebook also offers cloud storage that is safe, secure, and convenient for recording observations and synthesis attempts.

For more information on the PerkinElmer Signals Notebook, please visit PerkinElmer www.perkinelmer.com/product/signals-notebook-signalsn.

About PerkinElmer

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. The company reported revenue of approximately $2.1 billion in 2016, has approximately 9,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available by calling 1-877-PKI-NYSE or at www.perkinelmer.com.

Follow us on Twitter @PKILifeScience.

Media Contact:
Alison Cizowski
+1 617-399-4914
perkinelmerdas@apcoworldwide.com


Royal Society of Chemistry

RSC

Advancing excellence in the chemical sciences

We are the world’s leading chemistry community, with a membership and professional society of over 53,500 members.

We publish high quality chemical science research. Our average journal Impact Factor1 is now 6.105 and continually increasing.

2017 Highlight: RSC Advances is open access (OA)

RSC Advances, the largest chemical sciences journal in the world has become a gold open access journal. This provides researchers free access to a broader scope of high quality research and offers new, affordable open access publishing options for authors around the world.

In January, we published our first fully gold open access issueof RSC Advances, featuring 75 articles from authors in 28 countries.

RSC Advances’ article processing charge (APC) is £750, one of the lowest in the industry. For the first two years, this charge will be discounted to £500, with further discounts and waiver options also available.

Our aim is to support the scientific community and advance excellence in the chemical sciences. Converting a journal of this size and reputation to open access cements our influence in OA publishing, and puts us in a strong position to shape its future for the benefit of our community

1) 2015 Journal Citation Reports, (Clarivate Analytics, June 2016)


Thieme Chemistry

Thieme Chemistry launches SynOpen

SynOpen - Theime

Stuttgart – SynOpen, the Thieme Publishing Group’s latest addition to its range of open access journals, reports on current research results in the field of chemical synthesis. The new English-language journal gives interested authors in chemistry the option to publish their articles in open access format. Manuscripts are currently being accepted.

The new open access publication, SynOpen, rounds off Thieme’s range of journals for synthetic chemists. “The launch of SynOpen gives chemical researchers the possibility to choose between publishing in an open access or a traditional subscription journal,” says Dr. Susanne Haak, Managing Editor at Thieme Chemistry. “This option is of increasing importance for our authors, as the requirements of financial backers and funding bodies are becoming more and more complex in this regard,” adds Haak.

Thieme encourages authors to submit full papers, letters or practical synthetic procedures (PSPs) in the field of chemical synthesis for publication in SynOpen. The journal covers all areas relating to organic synthesis, including catalysis, organometallics, medicinal chemistry, biological chemistry, and photochemistry, as well as related disciplines, such as materials science. Researchers are also invited to publish the primary data of their experiments. All submitted manuscripts are peer-reviewed by experts to ensure the same high level of quality that readers have come to expect from the Thieme subscription journals Synthesis, Synlett, and Synfacts. The publishers were able to bring an experienced editor, Professor Laurence M. Harwood, on board for the new journal, whose work at the University of Reading, U.K., includes the development of new synthetic methods and their application to the synthesis of natural and unnatural products. For some years he has also been working in the field of nuclear chemistry.

Authors interested in publishing articles in SynOpen can find all the information they need at www.thieme-chemistry.com/synopen.

The Thieme Publishing Group’s product range in the field of chemical synthesis also includes the English-language journals Synthesis, Synlett, and Synfacts. Each journal has its own board of internationally renowned editors to ensure that chemists have access to the latest high-quality research results in their areas of specialization.